Early experience utilizing bivalirudin as anticoagulation in extracorporeal membrane oxygen in coronavirus disease 2019

Back

ESC Premium Access

Early experience utilizing bivalirudin as anticoagulation in extracorporeal membrane oxygen in coronavirus disease 2019

Session: COVID-19 and cardiovascular pharmacotherapy

Topic: Anticoagulants

Speaker: Doctor C. Jones (West Palm Beach, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Can Jones

HCA Florida JFK Hospital, West Palm Beach (United States of America)

0 follower

4 more presentations in this session

Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis.

Speaker: Doctor A. Pani (Milan, IT)

Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).

Speaker: Doctor F. Santoro (Foggia, IT)

Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients

Speaker: Doctor C. Diaz-Arocutipa (Lima, PE)

Management and impact of atrial fibrillation in the COVID 19 era; concomitancy of two procoagulant phenomena

Speaker: Doctor A. Arteagoitia Bolumburu (Madrid, ES)

Access the full session

COVID-19 and cardiovascular pharmacotherapy

Speakers: Doctor C. Jones, Doctor A. Pani, Doctor F. Santoro, Doctor C. Diaz-Arocutipa, Doctor A. Arteagoitia Bolumburu

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources